Cargando…
Dual-vector prodrug activator gene therapy using retroviral replicating vectors
Retroviral replicating vectors (RRVs) have been shown to achieve efficient tumor transduction and enhanced therapeutic benefits in a variety of cancer models. In the present study, we evaluated a possible combinatorial effect of prodrug activator genes delivered by two different RRVs derived from am...
Autores principales: | Kubo, Shuji, Takagi-Kimura, Misato, Tagawa, Masatoshi, Kasahara, Noriyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760537/ https://www.ncbi.nlm.nih.gov/pubmed/30348946 http://dx.doi.org/10.1038/s41417-018-0051-0 |
Ejemplares similares
-
Efficient tumor transduction and antitumor efficacy in experimental human osteosarcoma using retroviral replicating vectors
por: Kubo, Shuji, et al.
Publicado: (2018) -
Retroviral Replicating Vectors Mediated Prodrug Activator Gene Therapy in a Gastric Cancer Model
por: Fujino, Hiroaki, et al.
Publicado: (2023) -
Retroviral Replicating Vector Toca 511 (Vocimagene Amiretrorepvec) for Prodrug Activator Gene Therapy of Lung Cancer
por: Kushiya, Hiroki, et al.
Publicado: (2022) -
Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma
por: Kawasaki, Yoshiko, et al.
Publicado: (2011) -
Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model
por: Chen, Shih-Han, et al.
Publicado: (2020)